FDA inspection
Second Pharma Co., Ltd.: FDA inspection ending Mar 17, 2017
FDA inspection 1009109 · Voluntary Action Indicated (VAI) · Shaoxing
Key facts
| Inspection ID | 1009109 |
|---|---|
| Firm | Second Pharma Co., Ltd. |
| FEI number | 3004836637 |
| Address | Hangzhou Bay Shangyu, No. 33 Weiwu Road; Industrial Area |
| City | Shaoxing |
| Country | China |
| Fiscal year | 2017 |
| Inspection end date | Mar 17, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data